Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Morphine (substance) |
Is a |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Product containing phenanthrene derivative (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
1 |
Phenanthrene derivative poisoning |
Causative agent |
True |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
1 |
Poisoning by dihydrocodeine |
Causative agent |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Accidental poisoning by dihydrocodeine |
Causative agent |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Intentional poisoning by dihydrocodeine |
Causative agent |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
forgiftning med dihydrocodein, uvist med hvilken hensigt |
Causative agent |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Nalbuphine poisoning |
Causative agent |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Accidental nalbuphine poisoning (disorder) |
Causative agent |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Intentional nalbuphine poisoning |
Causative agent |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
forgiftning med nalbuphin, uvist med hvilken hensigt |
Causative agent |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Levorphanol (substance) |
Is a |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Codeine (substance) |
Is a |
True |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Dihydrocodeine (substance) |
Is a |
True |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Kaolin and morphine mixture BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Product containing precisely morphine sulfate 15 milligram/1 each conventional release rectal suppository (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 10 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 20 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morfinsulfat 10 mg/5 ml oral enhedsdosis, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morfinsulfat 30 mg/5 ml oral enhedsdosis, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morfinsulfat 100 mg/5 ml oral enhedsdosis, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Product containing precisely morphine sulfate 2 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morfinsulfat 100 mg/5 ml oral opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 20 mg brev granulat til suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 30 mg brev granulat til suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine hydrochloride 15 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine hydrochloride 30 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinhydrochlorid pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 30 mg rectal suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 20 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 5 mg tablet ed modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 10 mg kapsel med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 15 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 30 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 60 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 100 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 200 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 60 mg brev granulat til suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 100 mg brev granulat til suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 200 mg brev granulat til suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 10 mg kapsel med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 30 mg kapsel med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 60 mg kapsel med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat kapsel med modificeret udløsning a 100 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 90 mg kapsel med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 120 mg kapsel med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat kapsel med modificeret udløsning a 150 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 200 mg kapsel med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat kapsel med modificeret udløsning a 20 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 50 mg kapsel med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 50 mg/50 ml i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 100 mg/50 ml i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 50 mg/50 ml injektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 100 mg/50 ml injektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morfinsulfat 20 mg/ml koncentreret oral opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 35 mg rektaltampon |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 50 mg rektaltampon |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 75 mg rektaltampon |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 100 mg rektaltampon |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 20 mg/1ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 30 mg/1ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 20 mg/2ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 30 mg/2 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 40 mg/2 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 10 mg/1 ml + atropinsulfat 600 µg/1ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Product containing kaolin and morphine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Product containing morphine in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat + atropinsulfat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphintabletter |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine tartrate+cyclizine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morfinopløsning til oral anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinhydrochlorid 10 mg/ml oral opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Product containing morphine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphingranulat til oral anvendelse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 10 mg/1 ml injektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 15 mg/1ml injektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 60 mg/2 ml injektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinkapsel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Product containing morphine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Opium and Morphine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine salts (1) [central nervous system use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinanalgetikum, oral opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine simple elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morfin + cocain oral opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine/cocaine/chlorpromazine elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine salts (3) [central nervous system use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine salts (2) [central nervous system use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 10 mg/ml liposom depotinjektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat + glucose |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine salts [anesthesia] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 30 mg/30 ml injektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 10 mg/1 ml i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
Morphine sulfate 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 2 mg/ml injektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 4 mg/ml injektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 5 mg/ml injektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|
morphinsulfat 8 mg/ml injektion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Phenanthrene derivative (substance) |
Inferred relationship |
Some |
|